within Pharmacolibrary.Drugs.ATC.R;

model R03CC10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Carbuterol is a beta-2 adrenergic agonist that was investigated as a bronchodilator for the treatment of asthma and other obstructive airway diseases. It is a sympathomimetic agent structurally related to other beta-2 agonists like salbutamol. Currently, carbuterol is not an approved medication in most countries and is rarely used clinically.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed pharmacokinetic studies or clinical publications reporting human PK parameters of carbuterol were found as of 2024. Parameters below are left blank or are estimates based on class information.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R03CC10;
